EMDT_European Medical Device Technology

European Medical Device Technology, Spring 2015

Issue link: http://dc.cn.ubm-us.com/i/481993

Contents of this Issue


Page 14 of 47

emdt.co.uk European Medical Device Technology Spring 2015 | 13 A French start-up has designed a handheld spectroscopy device that performs approximately 10 common blood tests. "Our idea is to avoid using reagents to examine the composition of blood," explained Mejdi Nciri, Archimej Technology's CEO. Nciri founded the start-up with two fellow engineering graduates of the Institute of Optics Graduate School in Essonne.Their Spectroscopy 2.0 optical technology consists of multiple light sources emitting different wavelength light beams: a spectral multiplexing unit, a suitable detector that collects light beams transmitted through blood samples, and a signal processor that determines wavelength absorp- tion by measuring accurately the absorption of the various spectral components of light beams. Leveraging this technology, the resulting device, dubbed the Beta-BioLED, measures the concentration of bio- chemical compounds in the blood by passing a light beam through the blood sample and studying the absorption of the light by the sample. It detects, for instance, cholesterol as well as billirubin and albumin levels for liver or renal pathologies. "All you have to do is put a drop of blood on a test strip inserted into the device. Once the real-time analysis is completed, the results display on a tablet or connected smarphone," according to Francisco Vega, Archimej Tech- nology's chief financial officer. Archimej Technology intends to market its handheld analyzer for less than €600. "We're not competing with conventional analysis laboratories, which perform up to 80 different tests," said Camille Pat, Archimej Technology's marketing manager. "Our technology is complementary. It costs €25 to do about 10 basic blood tests in a laboratory. We expect to offer the same service for only 1€." The company is initially targeting healthcare profes- sionals working either for nongovernmental organisations (NGOs) in developing countries, or with reduced mobility patients in medicaly underserved regions. It plans to extend to the general public market by using the same business model as glucose monitors sold directly to diabetics. The first version of Beta-BioLED should be on the mar- ket by 2016. However, a major R&D effort is still needed to achieve this target, according to the company. Archimej Technology intends to raise three-million euros to speed up this development. — Bernard Banga, MD Report, France French Company Develops Tricorder-Like Blood Analyzer in the palm of your hand KNF introduces a 16 bar pressure liquid pump KNF Flodos AG, Product Center Liquid Pumps, Wassermatte 2, CH-6210 Sursee, Switzerland Tel: +41 (0)41 925 00 25 Fax: +41 (0)41 925 00 37 'OCKNOCTMGVKPI"MPHƃQFQUEJ YYYMPHEQO • 16 bar continuously • JKIJEJGOKECNTGUKUVCPEG 2''- • micro design • can run dry • self priming • maintenance-free • SWKEMJ[FTCWNKEEQPPGEVKQPU 16 bar MEDTEC Stuttgart Stand 3F40

Articles in this issue

Links on this page

Archives of this issue

view archives of EMDT_European Medical Device Technology - European Medical Device Technology, Spring 2015